Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates

• Status: Unknown status
• Trial end date: 2019-05-01

Summary

The purpose of the study is to evaluate the efficacy and safety of Cadisurf (goat lung surfactant extract) as compared to Survanta (beractant) in the treatment of respiratory distress syndrome in preterm neonates (with gestation of 26 to 32 weeks).

• Phase: Phase 2/Phase 3

Details

• Lead Sponsor: Ramesh K Agarwal
• Collaborators: All India Institute of Medical Sciences, New Delhi; Chacha Nehru Bal Chikitsalya, Delhi; Government Medical College, Chandigarh; Institute of Child health and Hospital for Children, Chennai; Jawaharlal Institute of Postgraduate Medical Education & Research; King Edward Memorial Hospital, Mumbai; King Edward Memorial Hospital, Pune; Lade Hardinge Medical College, New Delhi; Lady Hardinge Medical College; Lokmanya Tilak Municipal General Hospital; Lokmanya Tilak Municipal General Hospital, Mumbai; Maulana Azad Medical College, New Delhi; Postgraduate Institute of Medical Education and Research, Chandigarh; St Johns Medical College Hospital, Bangalore, India; St. John's Medical College, Bangalore; Wellcome Trust
• Treatments: Beractant; Goat lung surfactant extract; Pulmonary Surfactants